$52.3 Million is the total value of SVB FINANCIAL GROUP's 28 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 37.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OKTA | Sell | OKTA INCcl a | $8,612,961 | +12.5% | 99,872 | -10.8% | 16.48% | -21.2% |
| Sell | DICE THERAPEUTICS INC | $832,741 | -37.0% | 29,066 | -31.4% | 1.59% | -55.9% | |
| CGEM | Sell | CULLINAN ONCOLOGY INC | $207,403 | -27.3% | 20,274 | -25.0% | 0.40% | -49.1% |
| GBIO | Sell | GENERATION BIO CO | $173,724 | -16.5% | 40,401 | -23.7% | 0.33% | -41.5% |
| Sell | CARIBOU BIOSCIENCES INC | $146,657 | -50.4% | 27,619 | -41.3% | 0.28% | -65.2% | |
| ALVR | Sell | ALLOVIR INC | $135,595 | -38.6% | 34,415 | -20.0% | 0.26% | -57.0% |
| KNTE | Sell | KINNATE BIOPHARMA INC | $97,425 | -31.7% | 15,588 | -33.3% | 0.19% | -52.3% |
| Sell | PARDES BIOSCIENCES INC | $75,109 | -43.0% | 56,901 | -26.9% | 0.14% | -60.0% | |
| ELDN | Sell | ELEDON PHARMACEUTICALS INC | $63,583 | -31.7% | 26,942 | -33.7% | 0.12% | -52.0% |
| Sell | NOGIN INC | $57,612 | -82.4% | 21,220 | -95.0% | 0.11% | -87.7% | |
| Exit | TEMPO AUTOMATION HOLDINGS IN | $0 | – | -20,813 | -100.0% | -0.04% | – | |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -22,422 | -100.0% | -0.06% | – |
| Exit | WAG GROUP CO | $0 | – | -42,262 | -100.0% | -0.36% | – | |
| Exit | SELINA HOSPITALITY PLC | $0 | – | -50,217 | -100.0% | -0.37% | – | |
| KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -4,653 | -100.0% | -0.61% | – |
| Exit | OWLET INC | $0 | – | -881,458 | -100.0% | -1.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COINBASE GLOBAL INC | 4 | Q3 2023 | 57.5% |
| OKTA INC | 4 | Q3 2023 | 20.9% |
| ROOT INC | 4 | Q3 2023 | 14.0% |
| AXSOME THERAPEUTICS INC | 4 | Q3 2023 | 7.1% |
| CAREMAX INC | 4 | Q3 2023 | 3.0% |
| PLANET LABS PBC | 4 | Q3 2023 | 2.0% |
| MOONLAKE IMMUNOTHERAPEUTICS | 4 | Q3 2023 | 1.7% |
| ROVER GROUP INC | 4 | Q3 2023 | 1.2% |
| CULLINAN ONCOLOGY INC | 4 | Q3 2023 | 0.8% |
| CARIBOU BIOSCIENCES INC | 4 | Q3 2023 | 0.8% |
View SVB FINANCIAL GROUP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | February 10, 2023 | 1,716,764 | 8.8% |
| Root, Inc. | February 10, 2023 | 783,012 | 8.6% |
| BigCommerce Holdings, Inc. | February 12, 2021 | 392,224 | 0.6% |
| ISC8 INC. /DE | February 17, 2015 | 34,533,213 | 11.9% |
View SVB FINANCIAL GROUP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 8-K | 2024-03-22 |
| 8-K | 2024-03-20 |
| 8-K | 2024-02-26 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 8-K | 2024-02-09 |
| 8-K | 2024-02-01 |
| 8-K | 2024-01-29 |
| SC 13G/A | 2024-01-17 |
| 8-K | 2024-01-10 |
View SVB FINANCIAL GROUP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.